Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

D. Tashkin · SciRah

Researcher profile · Semantic Scholar

D. Tashkin

Share profile

D. Tashkin — researcher profile on SciRah

h-index: 100
Works: 672
Citations: 34K

Most-cited papers

Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease
D. Khanna, D. Tashkin, C. Denton, E. Renzoni +2 more
2019American Journal of Respiratory and Critical Care Medicine154 citations Open access
Semantic Scholar
Spirometric Indices of Early Airflow Impairment in Individuals at Risk of Developing COPD: Spirometry Beyond FEV1/FVC
D. Hoesterey, N. Das, W. Janssens, R. Buhr +4 more
2019Respiratory Medicine76 citations Open access
Semantic Scholar
Pulmonary effects of inhaled cannabis smoke
D. Tashkin, M. Roth
2019The American Journal of Drug and Alcohol Abuse74 citations
Semantic Scholar
The effect of e-cigarette aerosol emissions on respiratory health: a narrative review
R. Polosa, Renée O’Leary, D. Tashkin, R. Emma +1 more
2019Expert Review of Respiratory Medicine72 citations Open access
Semantic Scholar
Mortality and Exacerbation Risk by Body Mass Index in Patients with COPD in TIOSPIR and UPLIFT
N. Putcha, A. Anzueto, P. Calverley, B. Celli +4 more
2021Annals of the American Thoracic Society49 citations Open access
Semantic Scholar
The Effects of Rare SERPINA1 Variants on Lung Function and Emphysema in SPIROMICS.
V. Ortega, Xing-Nan Li, W. O'Neal, Lela Lackey +51 more
2020American Journal of Respiratory and Critical Care Medicine49 citations Open access
Semantic Scholar
Treatment With Mycophenolate and Cyclophosphamide Leads to Clinically Meaningful Improvements in Patient‐Reported Outcomes in Scleroderma Lung Disease: Results of Scleroderma Lung Study II
E. Volkmann, D. Tashkin, Holly Leclair, M. Roth +5 more
2020ACR Open Rheumatology48 citations Open access
Semantic Scholar
Minimal Clinically Important Differences for the Modified Rodnan Skin Score: Results from the Scleroderma Lung Studies (SLS-I and SLS-II)
D. Khanna, P. Clements, E. Volkmann, Holly M Wilhalme +5 more
2019Arthritis Research & Therapy45 citations Open access
Semantic Scholar
Comparing Randomized Controlled Trials and Real-World Studies in Chronic Obstructive Pulmonary Disease Pharmacotherapy
D. Tashkin, A. Amin, E. Kerwin
2020International Journal of COPD40 citations Open access
Semantic Scholar
Cyclophosphamide for Systemic Sclerosis-Related Interstitial Lung Disease: A Comparison of Scleroderma Lung Studies I and II
E. Volkmann, D. Tashkin, M. Sim, Ning Li +8 more
2019Journal of Rheumatology36 citations Open access
Semantic Scholar
Benefit:Risk Profile of Budesonide in Obstructive Airways Disease
D. Tashkin, B. Lipworth, R. Brattsand
2019Drugs34 citations Open access
Semantic Scholar
Predictive Significance of Serum Interferon Inducible Protein Score for Response to Treatment in Systemic Sclerosis Related Interstitial Lung Disease
S. Assassi, Ning Li, E. Volkmann, M. Mayes +19 more
2020Arthritis & Rheumatology33 citations Open access
Semantic Scholar
Effect of mesenchymal stromal cell infusions on lung function in COPD patients with high CRP levels
D. Weiss, K. Segal, R. Casaburi, J. Hayes +1 more
2021Respiratory Research31 citations Open access
Semantic Scholar
Longitudinal Follow-Up of Participants With Tobacco Exposure and Preserved Spirometry.
W. Mckleroy, T. Shing, W. Anderson, M. Arjomandi +34 more
2023Journal of the American Medical Association (JAMA)29 citations Open access
Semantic Scholar
Early Radiographic Progression of Scleroderma
E. Volkmann, D. Tashkin, M. Roth, J. Goldin +1 more
2021Chest29 citations Open access
Semantic Scholar
Significance of FEV3/FEV6 in recognition of early airway disease in smokers at risk of development of COPD: Analysis of the SPIROMICS cohort.
N. Yee, D. Markovic, R. Buhr, S. Fortis +18 more
2021Chest29 citations Open access
Semantic Scholar
Using transitional changes on HRCT to monitor the impact of cyclophosphamide or mycophenolate on systemic sclerosis-related interstitial lung disease
G. Kim, D. Tashkin, P. Lo, Matthew S. Brown +7 more
2019Arthritis & Rheumatology29 citations Open access
Semantic Scholar
The use of nebulized pharmacotherapies during the COVID-19 pandemic
S. Sethi, I. Barjaktarevic, D. Tashkin
2020Therapeutic Advances in Respiratory Disease28 citations Open access
Semantic Scholar
Intravenous versus oral cyclophosphamide for lung and/or skin fibrosis in systemic sclerosis: an indirect comparison from EUSTAR and randomised controlled trials.
C. Bruni, D. Tashkin, V. Steen, Y. Allanore +4 more
2020Clinical and Experimental Rheumatology27 citations
Semantic Scholar
STRATUS: A Phase II Study of Abituzumab in Patients With Systemic Sclerosis–associated Interstitial Lung Disease
D. Khanna, D. Tashkin, A. Wells, J. Seibold +5 more
2020Journal of Rheumatology26 citations Open access
Semantic Scholar
Peripheral blood gene expression profiling shows predictive significance for response to mycophenolate in systemic sclerosis related interstitial lung disease
S. Assassi, E. Volkmann, W. Zheng, Xuan Wang +4 more
2022Annals of the Rheumatic Diseases25 citations Open access
Semantic Scholar
Sex differences in clinical outcomes and biological profiles in systemic sclerosis-associated interstitial lung disease: a post-hoc analysis of two randomised controlled trials
E. Volkmann, D. Tashkin, R. Silver, C. Bostwick +7 more
2022The Lancet Rheumatology23 citations Open access
Semantic Scholar
Association of symptoms of gastroesophageal reflux, esophageal dilation and progression of systemic sclerosis-related interstitial lung disease
E. Volkmann, D. Tashkin, M. Leng, G. Kim +2 more
2022Arthritis care & research21 citations Open access
Semantic Scholar
A Close Look at Vaping in Adolescents and Young Adults in the USA.
R. Polosa, T. Casale, D. Tashkin
2022Journal of Allergy and Clinical Immunology: In Practice19 citations Open access
Semantic Scholar
Blood neutrophil count and neutrophil-to-lymphocyte ratio predict disease progression and mortality in two independent systemic sclerosis cohorts
Nancy Wareing, V. Mohan, Rana Taherian, E. Volkmann +8 more
2022Arthritis care & research19 citations Open access
Semantic Scholar
Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis
I. Barjaktarevic, R. Buhr, Xiaoyan Wang, Scott Hu +30 more
2019International Journal of COPD19 citations Open access
Semantic Scholar
Systemic Sclerosis Associated Interstitial Lung Disease: A Conceptual Framework for Subclinical, Clinical, and Progressive Disease.
D. Roofeh, K. Brown, E. Kazerooni, D. Tashkin +49 more
2022Rheumatology18 citations Open access
Semantic Scholar
The Role of ICS/LABA Fixed-Dose Combinations in the Treatment of Asthma and COPD: Bioequivalence of a Generic Fluticasone Propionate-Salmeterol Device
D. Tashkin, J. Ohar, A. Koltun, R. Allan +1 more
2021Pulmonary Medicine18 citations Open access
Semantic Scholar
Nebulized Treatments and the Possible Risk of Coronavirus Transmission: Where Is the Evidence?
D. Tashkin, I. Barjaktarevic
2020Chronic obstructive pulmonary diseases18 citations Open access
Semantic Scholar
Panlobular emphysema is associated with COPD disease severity: A study of emphysema subtype by computed tomography.
M. Wilgus, F. Abtin, D. Markovic, D. Tashkin +6 more
2021Respiratory Medicine16 citations Open access
Semantic Scholar
Chronic toxicity of inhaled thymol in lungs and respiratory tracts in mouse model
Kevin Xie, D. Tashkin, M. Z. Luo, J. Zhang
2019Pharmacology Research & Perspectives16 citations Open access
Semantic Scholar
Determining progression of scleroderma-related interstitial lung disease
E. Volkmann, D. Tashkin, M. Sim, Grace H. Kim +2 more
2018Journal of Scleroderma and Related Disorders16 citations Open access
Semantic Scholar
Cannabis consumption is associated with lower COVID-19 severity among hospitalized patients: a retrospective cohort analysis
Carolyn M. Shover, Peter Yan, N. Jackson, R. Buhr +3 more
2022Journal of Cannabis Research14 citations Open access
Semantic Scholar
Combining Clinical and Biological Data to Predict Progressive Pulmonary Fibrosis in Patients With Systemic Sclerosis Despite Immunomodulatory Therapy
E. Volkmann, Holly M Wilhalme, S. Assassi, G. Kim +4 more
2023ACR Open Rheumatology13 citations Open access
Semantic Scholar
Use of a Wearable Biosensor to Study Heart Rate Variability in Chronic Obstructive Pulmonary Disease and Its Relationship to Disease Severity
S. Park, N. Saiphoklang, D. Jung, D. Gomez +5 more
2022Italian National Conference on Sensors13 citations Open access
Semantic Scholar
Black carbon content in airway macrophages is associated with increased severe exacerbations and worse COPD morbidity in SPIROMICS
V. Tejwani, H. Woo, Chen Liu, Anna Tillery +23 more
2022Respiratory Research13 citations Open access
Semantic Scholar
Clinical implications of low absolute blood eosinophil count in the SPIROMICS COPD cohort.
W. Lemaster, P. Quibrera, D. Couper, D. Tashkin +19 more
2022Chest13 citations Open access
Semantic Scholar
Differential Effects of Electronic Hookah Vaping and Traditional Combustible Hookah Smoking on Oxidation, Inflammation, and Arterial Stiffness
M. Rezk-Hanna, Rajat Gupta, Charlie O. Nettle, D. Dobrin +5 more
2021Chest13 citations Open access
Semantic Scholar
Inhaled Marijuana and the Lung.
D. Tashkin, Wan-Cheng Tan
2022Journal of Allergy and Clinical Immunology: In Practice12 citations
Semantic Scholar
Significance of FEV3/FEV6 in Recognition of Early Airway Disease in Smokers at Risk of Development of COPD: Analysis of the SPIROMICS Cohort
N. Yee, D. Markovic, R. Buhr, D. Tashkin +24 more
202012 citations
Semantic Scholar
Smoking cessation in COPD: confronting the challenge
D. Tashkin
2021Internal and Emergency Medicine11 citations Open access
Semantic Scholar
Ratio of Forced Expiratory Volume in 1 second /Slow Vital Capacity (FEV1/SVC)<0.7 is associated with clinical, functional, and radiologic features of obstructive lung disease in smokers with preserved lung function.
S. Fortis, A. Comellas, S. Bhatt, E. Hoffman +28 more
2021Chest11 citations Open access
Semantic Scholar
Bronchodilator Responsiveness in Tobacco-Exposed Persons with or without COPD.
S. Fortis, P. Quibrera, A. Comellas, S. Bhatt +24 more
2022Chest10 citations Open access
Semantic Scholar
Effect of smoking status on lung function, patient-reported outcomes, and safety among COPD patients treated with glycopyrrolate inhalation powder: pooled analysis of GEM1 and GEM2 studies
D. Tashkin, T. Goodin, A. Bowling, Barry Price +3 more
2019Respiratory Research10 citations Open access
Semantic Scholar
Reversible Airflow Obstruction Predicts Future COPD Development in the SPIROMICS Cohort.
R. Buhr, I. Barjaktarevic, P. Quibrera, Lori A. Bateman +15 more
2022American Journal of Respiratory and Critical Care Medicine9 citations Open access
Semantic Scholar
Normal Routine Spirometry Can Mask COPD/Emphysema in Symptomatic Smokers.
A. Gelb, Alfred Yamamoto, E. Verbeken, J. Hogg +8 more
2021Chronic obstructive pulmonary diseases9 citations Open access
Semantic Scholar
Formoterol for the Treatment of Chronic Obstructive Pulmonary Disease
D. Tashkin
2020International Journal of COPD9 citations Open access
Semantic Scholar
Racial Disparities in Systemic Sclerosis: Short‐ and Long‐Term Outcomes Among African American Participants of SLS I and II
E. Volkmann, V. Steen, Ning Li, M. Roth +8 more
2020ACR Open Rheumatology9 citations Open access
Semantic Scholar
OUTCOME MEASUREMENT INSTRUMENT SELECTION FOR LUNG PHYSIOLOGY IN SYSTEMIC SCLEROSIS ASSOCIATED INTERSTITIAL LUNG DISEASE: A SYSTEMATIC REVIEW USING THE OMERACT FILTER 2.1 PROCESS
D. Roofeh, S. Barratt, A. Wells, Letícia Kawano-Dourado +18 more
2021Seminars in Arthritis & Rheumatism8 citations Open access
Semantic Scholar
Heroin Smoking and COPD: A Case for Targeted Screening Spirometry.
D. Tashkin
2019Chest8 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

I. Barjaktarevic×15
Invite
I. Barjaktarevic — researcher profile on SciRah
E. Volkmann×14
Invite
E. Volkmann — researcher profile on SciRah
D. Khanna×10
Invite
D. Khanna — researcher profile on SciRah
R. Paine×10
Invite
R. Paine — researcher profile on SciRah

×10

Invite

P. Woodruff — researcher profile on SciRah

Invite

R. Buhr — researcher profile on SciRah

Invite

D. Couper — researcher profile on SciRah

Mei-Lan K. Han×9

Invite

Mei-Lan K. Han — researcher profile on SciRah

Invite

R. Barr — researcher profile on SciRah

Invite

R. Kanner — researcher profile on SciRah

Invite

F. Martinez — researcher profile on SciRah

Invite

R. Bowler — researcher profile on SciRah